Quadrant Private Wealth Management, LLC Biogen Inc. Transaction History

Quadrant Private Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $212,870 - $320,422	-901 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $1,853 - $2,139	-7 Reduced 0.77%	901 $256,000
Q2 2020 Aug 04, 2020	BUY	$258.66 - $342.55 $71,648 - $94,886	277 Added 43.9%	908 $243,000
Q1 2020 May 08, 2020	BUY	$268.85 - $341.04 $169,644 - $215,196	631 New	631 $200,000

1,050

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Quadrant Private Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Quadrant Private Wealth Management, LLC with notifications on news.